Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Arbutus Biopharma Corporation (ABUS) is the issuer whose common shares are covered by an amended beneficial-ownership report. Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi each report the same fund-held position of 8,143,994 shares, or 4.1%, as of September 30, 2026. The shares are held by Two Seas Global (Master) Fund LP (6,152,903 shares) and Two Seas LNP Opportunities (Master) Fund LP (1,991,091 shares).
The report attributes sole voting and dispositive power over the position to each reporting person; none reports shared voting or dispositive power. Two Seas Capital LP is the Funds' investment manager, Two Seas Capital GP LLC is its general partner, and Sina Toussi is the investment adviser's chief investment officer and the GP's managing member. The reported 4.1% is based on 199,275,907 ABUS common shares outstanding as of September 30, 2026.
Key Figures
Beneficially owned:8,143,994 sharesPercent of class:4.1%Global Fund holdings:6,152,903 shares+2 more
5 metrics
Beneficially owned8,143,994 sharesPosition reported by each of the three reporting persons as of September 30, 2026
Percent of class4.1%Reported for each reporting person as of September 30, 2026
Global Fund holdings6,152,903 sharesShares held by Two Seas Global (Master) Fund LP
LNP Opportunities Fund holdings1,991,091 sharesShares held by Two Seas LNP Opportunities (Master) Fund LP
Common shares outstanding199,275,907 sharesAs of September 30, 2026; denominator used for the reported percentages
Key Terms
beneficially owned, sole power to vote, sole power to dispose, investment discretion
4 terms
beneficially ownedregulatory
"Amount beneficially owned as of September 30, 2026"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole power to voteregulatory
"had sole power to vote or to direct the vote"
sole power to disposeregulatory
"had sole power to dispose or to direct the disposition"
investment discretionfinancial
"granted investment discretion over portfolio investments"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many ABUS shares did Two Seas Capital report beneficially owning?
The report attributes 8,143,994 ABUS common shares to each of Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi, equal to 4.1% of the class as of September 30, 2026. These are overlapping attributions of the same fund-held position.
Which funds hold the ABUS shares reported by Two Seas?
Two Seas Global (Master) Fund LP holds 6,152,903 shares, and Two Seas LNP Opportunities (Master) Fund LP holds 1,991,091 shares. The report states that the Funds' shares are subject to investment discretion by Two Seas Capital LP.
Who has voting and dispositive power over the reported ABUS shares?
The report attributes sole voting and sole dispositive power over 8,143,994 shares to each reporting person: Two Seas Capital LP, Two Seas Capital GP LLC, and Sina Toussi. It reports zero shared voting power and zero shared dispositive power.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Arbutus Biopharma Corporation
(Name of Issuer)
Common Shares, without par value
(Title of Class of Securities)
03879J100
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
03879J100
1
Names of Reporting Persons
Two Seas Capital LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
8,143,994.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
8,143,994.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,143,994.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.1 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
CUSIP Number(s):
03879J100
1
Names of Reporting Persons
Two Seas Capital GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
8,143,994.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
8,143,994.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,143,994.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.1 %
12
Type of Reporting Person (See Instructions)
HC, OO
SCHEDULE 13G
CUSIP Number(s):
03879J100
1
Names of Reporting Persons
Sina Toussi
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
8,143,994.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
8,143,994.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
8,143,994.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.1 %
12
Type of Reporting Person (See Instructions)
IN, HC
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Arbutus Biopharma Corporation
(b)
Address of issuer's principal executive offices:
701 Veterans Circle, Warminster, PA 18974
Item 2.
(a)
Name of person filing:
The Statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons")
(i) Two Seas Capital LP ("TSC");
(ii) Two Seas Capital GP LLC ("TSC GP"); and
(iii) Sina Toussi.
This statement relates to Common Shares, without par value (the "Common Shares"), held by Two Seas Global (Master) Fund LP (the "Global Fund") and Two Seas LNP Opportunities (Master) Fund LP (the "LNP Opportunities Fund," and together with the Global Fund, the "Funds"). The principal business of TSC is providing investment advice as a registered investment adviser and serving as investment manager to the Funds and other advisory clients. As such, TSC has been granted investment discretion over portfolio investments, including the Common Shares, held by or for the account of the Funds, including the Funds' voting and discretionary decisions. TSC GP serves as general partner of TSC. Sina Toussi serves as the chief investment officer of TSC and managing member of TSC GP.
(b)
Address or principal business office or, if none, residence:
The address of the principal business office of each of the Reporting Persons is 32 Elm Place - 3rd Floor, Rye, New York 10580.
(c)
Citizenship:
(i) Two Seas Capital LP is a Delaware limited partnership;
(ii) Two Seas Capital GP LLC is a Delaware limited liability company; and
(iii) Sina Toussi is a United States citizen.
(d)
Title of class of securities:
Common Shares, without par value
(e)
CUSIP No.:
03879J100
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Amount beneficially owned as of September 30, 2026:
TSC - 8,143,994 shares of Common Shares
TSC GP - 8,143,994 shares of Common Shares
Sina Toussi - 8,143,994 shares of Common Shares
(b)
Percent of class:
Percent of class as of September 30, 2026:
TSC - 4.1%
TSC GP - 4.1%
Sina Toussi - 4.1%
The Common Shares reported for Item 4 total 8,143,994, of which 6,152,903 are held by the Global Fund and 1,991,091 are held by the LNP Opportunities Fund. TSC may be deemed to have sole power to vote and sole power to dispose of the Common Shares held by the Funds, through its capacity as investment adviser of the Funds. TSC GP may be deemed to have sole power to vote and sole power to dispose of the Common Shares held by the Funds, through its capacity as general partner of TSC. Sina Toussi may be deemed to have sole power to vote and sole power to dispose of the Common Shares owned by the Funds, through his capacity as Managing Member of TSC GP.
The percentages reported for Item 4(b) are calculated based on a total of 199,275,907 Common Shares outstanding on September 30, 2026, as disclosed in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on November 10, 2026.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
As of September 30, 2026, the Reporting Persons had sole power to vote or to direct the vote of 8,143,994 shares of Common Shares.
(ii) Shared power to vote or to direct the vote:
As of September 30, 2026, the Reporting Persons had shared power to vote or to direct the vote of 0 shares of Common Shares.
(iii) Sole power to dispose or to direct the disposition of:
As of September 30, 2026, the Reporting Persons had sole power to dispose or to direct the disposition of 8,143,994 shares of Common Shares.
(iv) Shared power to dispose or to direct the disposition of:
As of September 30, 2026, the Reporting Persons had shared power to dispose or to direct the disposition of 0 shares of Common Shares.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See disclosure in Item 4, which is incorporated by reference herein.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See disclosure in Item 2, which is incorporated by reference herein.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Two Seas Capital LP
Signature:
/s/ Sina Toussi
Name/Title:
Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner